Tofacitinib, 5 g

Tofacitinib carries a recognized safety classification for professional environments, identified as a white crystalline powder with a molecular formula of C28H33F3N5O4S and a molecular weight of 609.6 g/mol. It is a kinase inhibitor, specifically targeting Janus kinases JAK1, JAK2, JAK3, and TYK2, which play essential roles in intracellular signaling pathways involved in inflammation and immune response. This compound is supplied in a 5 gram pack as a fine powder, making it suitable for various pharmaceutical applications. Additionally, Tofacitinib exhibits high oral bioavailability and selectivity towards its intended targets, contributing to its efficacy in the treatment of rheumatoid arthritis and other inflammatory diseases.

• CAS Number: 477600-75-2